(5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
CAS: 363-24-6
Ref. IN-DA0034RV
1mg | 88,00 € | ||
10mg | 118,00 € | ||
100mg | 527,00 € | ||
250mg | 559,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
- Compuestos relacionados con ingredientes farmacéuticos activos (API) para investigación
- Ingredientes farmacéuticos activos (API) para investigación
- Compuestos y reactivos bioquímicos
- Investigación sobre el cáncer
- Reactivos de cultivo celular
- Biología celular y molecular
- Compuestos orgánicos quirales
- Ácidos grasos
- Inmunología e inflamación
- Lípidos
- Neurociencia
- Compuestos y metabolitos farmacéuticos y veterinarios
Información del producto
Nombre:
(5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
Sinónimos:
- Dinoprostone
- Gel, Prepidil
- Prepidil Gel
- Prostenon
- Dinoprostone
- Prepidil
- Cervidil
- Propess
- Dinoproston
- Prostin
- Ver más sinónimos
- Prostarmon E
- Dinoprostonum
- Dinoprostona
- Prostaglandin E
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
- l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
- (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-
- Prostaglandin E(2)
- (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid
- (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
- (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate
- Prepidil Gel
- (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-
- 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
- (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid
- 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
- Cerviprime
- Prostenone
- Enzaprost E
- Prostin E
- Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo-
- (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-
- Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
- Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
- 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid
- [3H]dinoprostone
- 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
- prosta-glandin e2
- (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid
- Dinoprostone beta-Cyclodextrin Clathrate
- prostaglandin-e2-cervidil
- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic
- (5Z,11|A,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
- (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate
- (5Z,11?,13E,15S)-11,15-Dihydroxy-9-oxo-prosta-5,13-dien-1oic acid
- (5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
- (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid
- (-)-Prostaglandin E<sub>2</sub>
- (11alpha,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (15S)-Prostaglandin E2
- (15S)-Prostaglandin E<sub>2</sub>
- (5E,13E)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oate
- (5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
- 11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11α,13E,15S)
- 11α,15α-Dihydroxy-9-ketoprosta-5,13-dienoic acid
- 11α,15α-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid
- 5-Heptenoic acid, 7-[3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
- 7-[3-Hydroxy-2-(3-Hydroxy-1-Octenyl)-5-Oxo-Cyclopentyl]-5-Heptenoic Acid
- Cerviprost
- Glandin
- Minprositin E2
- Minprositin E<sub>2</sub>
- Minprostin E2
- Minprostin E<sub>2</sub>
- Nsc 165560
- Nsc 196514
- PGE<sub>2</sub>
- Pge2
- Primiprost
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S)-
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8ξ,12ξ,13E)-
- Prosta-5,13-diene-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E15S)-
- Prostin (prostaglandin)
- Prostin E2
- Prostin E<sub>2</sub>
- U 12062
- Vivelle-Dot
- l-PGE2
- l-PGE<sub>2</sub>
- l-Prostaglandin E2
- l-Prostaglandin E<sub>2</sub>
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Indagoo
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
352.4651
Fórmula:
C20H32O5
Pureza:
98%
Color/Forma:
Solid
InChI:
InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1
Clave InChI:
XEYBRNLFEZDVAW-ARSRFYASSA-N
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
Consulta técnica sobre: IN-DA0034RV (5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.